« Tufts Report on Academic-Biopharm Partnerships | Main | Berwick: Cost Effectiveness is Permanent Condition »

05/01/2012

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b016765f8a610970b

Listed below are links to weblogs that reference More on Abbott Anti-Biosimilar Petition to FDA:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

More comment on this story from the PharmTech Talk blog and with similar conclusion that Abbott argument likely to see light of day in court
http://blog.pharmtech.com/2012/05/02/abbott-requests-indefinite-protection-from-biosimilars-competition/

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada